Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Johnston

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
World Journal of Gastroenterology|July 12, 2019
Immunotherapy for hepatocellular carcinoma: Current and futureMichael P Johnston, Salim I Khakoo
Current Opinion in Cardiology|June 1, 2021
Update on cardiovascular risk in nonalcoholic fatty liver diseaseMichael P Johnston, Janisha Patel, Christopher D Byrne
Scottish Medical Journal|September 3, 2019
Fatal Pneumocystis jirovecii pneumonia in a non-immunocompromised patient with alcohol-related liver cirrhosisNicholas J Hadfield, Subothini Selvendran, Michael P Johnston
Current Pharmaceutical Design|February 1, 2020
Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD)Michael P Johnston, Janisha Patel, Christopher D Byrne
Expert Opinion on Investigational Drugs|September 17, 2019
Multi-drug approaches to NASH: what's in the development pipeline?Michael P Johnston, Janisha Patel, Christopher D Byrne
Liver International : Official Journal of the International Association for the Study of the Liver|February 25, 2020
Non-invasive liver fibrosis scores are strongly associated with liver cancer mortality in general population without liver diseaseKi-Chul Sung, Michael P Johnston, Mi Y Lee, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
World Journal of Gastroenterology|July 12, 2019
Immunotherapy for hepatocellular carcinoma: Current and futureMichael P Johnston, Salim I Khakoo
Current Opinion in Cardiology|June 1, 2021
Update on cardiovascular risk in nonalcoholic fatty liver diseaseMichael P Johnston, Janisha Patel, Christopher D Byrne
Scottish Medical Journal|September 3, 2019
Fatal Pneumocystis jirovecii pneumonia in a non-immunocompromised patient with alcohol-related liver cirrhosisNicholas J Hadfield, Subothini Selvendran, Michael P Johnston
Current Pharmaceutical Design|February 1, 2020
Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD)Michael P Johnston, Janisha Patel, Christopher D Byrne
Expert Opinion on Investigational Drugs|September 17, 2019
Multi-drug approaches to NASH: what's in the development pipeline?Michael P Johnston, Janisha Patel, Christopher D Byrne
Liver International : Official Journal of the International Association for the Study of the Liver|February 25, 2020
Non-invasive liver fibrosis scores are strongly associated with liver cancer mortality in general population without liver diseaseKi-Chul Sung, Michael P Johnston, Mi Y Lee, et al.
Pageof 1